Antihistamine recall across the U.S. triggered by heartburn drug contamination risk, FDA says

Antihistamine recall across the U.S. triggered by heartburn drug contamination risk, FDA says

A generic model of the brand-name allergy treatment Zyrtec is beneath recall across the U.S. as a result of potential cross-contamination with a heartburn drug, in line with the Food and Drug Administration.  Drugmaker Unique Pharmaceutical Laboratories is voluntarily recalling antihistamine medicine, generally used to deal with seasonal allergic reactions, over potential cross-contamination with ranitidine,…

Read More